IL162646A0 - A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer - Google Patents
A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancerInfo
- Publication number
- IL162646A0 IL162646A0 IL16264603A IL16264603A IL162646A0 IL 162646 A0 IL162646 A0 IL 162646A0 IL 16264603 A IL16264603 A IL 16264603A IL 16264603 A IL16264603 A IL 16264603A IL 162646 A0 IL162646 A0 IL 162646A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical formulation
- cancer
- polyphenols
- treatment
- nutrient pharmaceutical
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 5
- 201000011510 cancer Diseases 0.000 title abstract 4
- 235000015097 nutrients Nutrition 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 235000013824 polyphenols Nutrition 0.000 title abstract 2
- 150000008442 polyphenolic compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 abstract 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 abstract 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 abstract 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 abstract 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 abstract 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 abstract 1
- 102100032912 CD44 antigen Human genes 0.000 abstract 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 abstract 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 abstract 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- 229930182821 L-proline Natural products 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 abstract 1
- 235000005487 catechin Nutrition 0.000 abstract 1
- 229950001002 cianidanol Drugs 0.000 abstract 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 abstract 1
- 235000012734 epicatechin Nutrition 0.000 abstract 1
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 abstract 1
- 229940030275 epigallocatechin gallate Drugs 0.000 abstract 1
- 108010069264 keratinocyte CD44 Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- -1 polyphenol compound Chemical class 0.000 abstract 1
- 229960002429 proline Drugs 0.000 abstract 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34814302P | 2002-01-11 | 2002-01-11 | |
| PCT/EP2003/000236 WO2003057201A2 (en) | 2002-01-11 | 2003-01-13 | A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162646A0 true IL162646A0 (en) | 2005-11-20 |
Family
ID=23366808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16264603A IL162646A0 (en) | 2002-01-11 | 2003-01-13 | A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US7041699B2 (ru) |
| EP (1) | EP1465614B1 (ru) |
| JP (1) | JP2005519055A (ru) |
| KR (1) | KR20040073559A (ru) |
| CN (1) | CN100377706C (ru) |
| AT (1) | ATE382343T1 (ru) |
| AU (1) | AU2003235762B2 (ru) |
| BR (1) | BR0302672A (ru) |
| CA (1) | CA2471932A1 (ru) |
| DE (1) | DE60318387T2 (ru) |
| EE (1) | EE200400032A (ru) |
| ES (1) | ES2298519T3 (ru) |
| HK (1) | HK1086489A1 (ru) |
| HR (1) | HRP20040704A2 (ru) |
| HU (1) | HUP0500498A3 (ru) |
| IL (1) | IL162646A0 (ru) |
| LT (1) | LT5240B (ru) |
| LV (1) | LV13248B (ru) |
| MX (1) | MXPA04006717A (ru) |
| NO (1) | NO20033950L (ru) |
| NZ (1) | NZ533737A (ru) |
| PL (1) | PL215159B1 (ru) |
| RU (1) | RU2301666C2 (ru) |
| UA (1) | UA80692C2 (ru) |
| WO (1) | WO2003057201A2 (ru) |
| YU (1) | YU75003A (ru) |
| ZA (1) | ZA200405075B (ru) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9034310B2 (en) * | 2002-02-21 | 2015-05-19 | Stephen B. Cantrell | Interferon-statin combination cancer therapy |
| US7115283B2 (en) * | 2003-05-06 | 2006-10-03 | Access Business Group International Llc | Preparations for sustained release of nutraceuticals and methods of controllably releasing nutraceuticals |
| US20040253319A1 (en) * | 2003-06-11 | 2004-12-16 | Shrirang Netke | Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy |
| MXPA06002534A (es) * | 2003-09-05 | 2006-06-20 | Matthias Rath | Composicion farmaceutica que comprende i.a. vitamina c, magnesio, extracto de te verde para retardar enfermedades cardiovasculares. |
| US20050176674A1 (en) * | 2004-02-09 | 2005-08-11 | Friesen Kim G. | Composition and method for use in cartilage affecting conditions |
| US8377904B2 (en) | 2004-02-09 | 2013-02-19 | Hill's Pet Nutrition, Inc. | Composition and method for use in cartilage affecting conditions |
| KR100601080B1 (ko) * | 2004-08-26 | 2006-07-19 | 가톨릭대학교 산학협력단 | (-)-에피갈로카테킨 갈레이트를 유효성분으로 하는류마티스성 관절염 치료제 |
| JP5156392B2 (ja) | 2005-02-03 | 2013-03-06 | トポターゲット ユーケー リミテッド | Ｈｄａｃ阻害剤を用いる併用療法 |
| BRPI0520221A2 (pt) | 2005-04-11 | 2009-04-22 | Matthias Rath | uso de uma composiÇço nutriente que compreende polifenàis de chÁ verde para tratamento de osteossarcoma |
| WO2006108429A1 (en) * | 2005-04-11 | 2006-10-19 | Matthias Rath | Nutrient composition for treating sarcoma and prostate cancer |
| EA018982B1 (ru) | 2005-05-13 | 2013-12-30 | Топотаргет Юкей Лимитед | Фармацевтические составы, содержащие ингибиторы деацетилазы гистонов |
| EP1924257A4 (en) * | 2005-07-26 | 2012-08-08 | Mitsui Norin Kk | STABILIZED 3-HYDROXYFLAVAN COMPOSITIONS AND METHOD THEREFOR |
| WO2007033356A2 (en) * | 2005-09-14 | 2007-03-22 | Mitsui Norin Co., Ltd | Compositions and methods for green tea catechins for modification of detoxification enzymes |
| WO2007054719A2 (en) * | 2005-11-10 | 2007-05-18 | Topotarget Uk Limited | Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent |
| US20070212426A1 (en) * | 2006-03-10 | 2007-09-13 | Matthias Rath | Composition and method of retarding viral activity and reducing viral replication |
| WO2007147128A2 (en) | 2006-06-16 | 2007-12-21 | Summa Health System | Non-toxic anti-cancer drug combining ascorbate, magnesium and a naphthoquinone |
| GB0615781D0 (en) * | 2006-08-09 | 2006-09-20 | Coressence Ltd | Prebiotic composition |
| US20080114054A1 (en) * | 2006-11-14 | 2008-05-15 | Rath Microbes | Compositions and methods for reducing antimicrobial resistance of microbes |
| US8617544B2 (en) * | 2007-05-01 | 2013-12-31 | Richard L. Kozlenko | Compositions and methods for controlling lipid metabolism |
| GB0710536D0 (en) | 2007-06-01 | 2007-07-11 | Veritron Ltd | Plant extract and its therapeutic use |
| CA2700173C (en) * | 2007-09-25 | 2016-10-11 | Topotarget Uk Limited | Methods of synthesis of certain hydroxamic acid compounds |
| GB0725077D0 (en) * | 2007-12-21 | 2008-01-30 | Univ Murcia | Antifolate com[ounds for the treatment of melanoma |
| CN102083428A (zh) * | 2008-03-07 | 2011-06-01 | 顶标公司 | 采用长时间连续输液Belinostat进行治疗的方法 |
| RU2395281C2 (ru) * | 2008-09-04 | 2010-07-27 | Всеволод Иванович Киселев | Фармацевтическая композиция для лечения диспластических процессов шейки матки |
| ES2534245T3 (es) | 2008-11-04 | 2015-04-20 | Vymedic, Llc | Formulaciones de suplemento antiviral |
| US8677463B2 (en) * | 2008-12-05 | 2014-03-18 | At&T Intellectual Property I, Lp | System and method for managing multiple sub accounts within a subcriber main account in a data distribution system |
| JP2009143928A (ja) * | 2008-12-26 | 2009-07-02 | Kyushu Univ | ガロイルカテキン類の抗酸化活性の促進方法 |
| GB0900555D0 (en) * | 2009-01-14 | 2009-02-11 | Topotarget As | New methods |
| CN101874822A (zh) * | 2009-04-27 | 2010-11-03 | 玫琳凯有限公司 | 植物性抗痤疮制剂 |
| IT1397522B1 (it) * | 2009-12-21 | 2013-01-16 | Solartium Entpr Ltd | Uso di una combinazione per il trattamento dell'osteoartrosi |
| GB201015784D0 (en) | 2010-09-20 | 2010-10-27 | Bionature E A Ltd | Anti-cancer compounds |
| EP2793848B1 (en) | 2011-12-19 | 2019-06-26 | Mary Kay, Inc. | Navy bean extract to whiten the skin and improve skin tone |
| RU2522547C1 (ru) * | 2012-11-12 | 2014-07-20 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации | Фармакологическая геропротекторная композиция и способ ее получения |
| US20140154702A1 (en) * | 2012-11-30 | 2014-06-05 | Endocyte, Inc. | Methods For Treating Cancer Using Combination Therapies |
| JP2016519092A (ja) * | 2013-03-18 | 2016-06-30 | デンタルメッド ファーム ホールディング リミテッド | 組成物におけるｎ−アセチルシステイン誘導体とクランベリーポリフェノールとの組み合わせ、並びに歯周疾患及びインプラント周囲炎を予防及び処置するための方法 |
| BE1023772B9 (fr) * | 2013-05-17 | 2017-08-02 | Valore | Composition a base d'un complexe de (+)-catechine et d'acide amine pour le traitement et la prevention du cancer |
| IN2013MU01528A (ru) * | 2013-07-26 | 2015-06-26 | Tata Memorial Ct | |
| GB2520794A (en) * | 2013-07-26 | 2015-06-03 | Tata Memorial Ct | Plant poly-phenol and copper (II) mediated degradation of DNA and RNA |
| KR102323049B1 (ko) | 2014-03-10 | 2021-11-05 | 마리 케이 인코포레이티드 | 피부 라이트닝 조성물 |
| BE1022579A9 (fr) * | 2014-11-10 | 2016-10-06 | Valore | Composition antimétastatique comprenant au moins un composé de type flavanol |
| CN105061533B (zh) * | 2015-09-18 | 2018-02-09 | 福州大学 | 六甲氧基二氢黄酮‑鼠李糖基‑鼠李糖苷及其应用 |
| CN106138036A (zh) * | 2016-04-29 | 2016-11-23 | 陈西敬 | 抗坏血酸棕榈酸酯在制备抗肿瘤药物中的应用 |
| CA3228010A1 (en) * | 2016-10-03 | 2018-04-12 | Houn Simon Hsia | Compositions and methods for enhancing cancer radiotherapy |
| CN111479577A (zh) | 2017-06-13 | 2020-07-31 | 夏滉 | 用于增强癌症放疗的组合物和方法 |
| US12029765B2 (en) | 2017-06-13 | 2024-07-09 | Houn Simon Hsia | Compositions and methods for treating cancer |
| KR20200079229A (ko) | 2017-06-13 | 2020-07-02 | 호운 사이먼 샤 | 암 화학요법을 강화시키기 위한 조성물 및 방법 |
| CN111529709A (zh) * | 2020-06-03 | 2020-08-14 | 北京易思腾翻译服务有限公司 | 一种可用于体重控制且可逆转动脉粥样硬化的组合物 |
| WO2022124386A1 (en) * | 2020-12-07 | 2022-06-16 | L' Oreal | Composition comprising ascorbic acid and cyclic amino acid |
| IT202200010592A1 (it) * | 2022-05-23 | 2023-11-23 | Neilos S R L | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4243363A1 (de) * | 1992-12-21 | 1994-06-23 | Ulrich Dr Med Kuebler | Behandlungsverfahren für Hauttrockenheit |
| US5962517A (en) * | 1997-01-31 | 1999-10-05 | Murad; Howard | Pharmaceutical compositions and methods for treating acne |
| US5817695A (en) * | 1997-12-24 | 1998-10-06 | Pellico; Michael A. | Nutritional product with high fat, low carbohydrate and amino acid imbalance |
| EP0938897A1 (en) * | 1997-12-26 | 1999-09-01 | Japanese Foundation For Cancer Research | Telomerase inhibitor |
| AT407821B (de) * | 1998-03-24 | 2001-06-25 | Franz Dr Stueckler | Mittel auf der basis von naturstoffen |
| AU4043900A (en) * | 1999-03-30 | 2000-10-16 | Purdue Research Foundation | Compositions containing tea catechins as cancer specific proliferation inhibitors |
| KR20020016833A (ko) | 1999-06-15 | 2002-03-06 | 뉴트리-로직스, 인크. | 발병 감소에 유용한 영양 제제, 관련 치료 방법 및 성분스크리닝 방법 |
| US6299925B1 (en) * | 1999-06-29 | 2001-10-09 | Xel Herbaceuticals, Inc. | Effervescent green tea extract formulation |
| US6448030B1 (en) * | 2000-02-18 | 2002-09-10 | University Of Nevada-Las Vegas | Method for predicting the efficacy of anti-cancer drugs |
| EP1195159B1 (en) * | 2000-10-09 | 2006-05-31 | Rath, Matthias, Dr. med. | Therapeutic combination of ascorbate with lysine and arginine for prevention and treatment of cancer |
| WO2007076492A2 (en) | 2005-12-28 | 2007-07-05 | Sandisk Corporation | Methods and systems for writing non-volatile memories for increased endurance |
-
2003
- 2003-01-13 JP JP2003557559A patent/JP2005519055A/ja active Pending
- 2003-01-13 KR KR10-2004-7010748A patent/KR20040073559A/ko not_active Application Discontinuation
- 2003-01-13 PL PL371282A patent/PL215159B1/pl unknown
- 2003-01-13 NZ NZ533737A patent/NZ533737A/en unknown
- 2003-01-13 ES ES03729250T patent/ES2298519T3/es not_active Expired - Lifetime
- 2003-01-13 BR BR0302672-8A patent/BR0302672A/pt not_active IP Right Cessation
- 2003-01-13 DE DE60318387T patent/DE60318387T2/de not_active Expired - Lifetime
- 2003-01-13 EP EP03729250A patent/EP1465614B1/en not_active Expired - Lifetime
- 2003-01-13 EE EEP200400032A patent/EE200400032A/xx unknown
- 2003-01-13 AU AU2003235762A patent/AU2003235762B2/en not_active Expired - Fee Related
- 2003-01-13 WO PCT/EP2003/000236 patent/WO2003057201A2/en active IP Right Grant
- 2003-01-13 CA CA002471932A patent/CA2471932A1/en not_active Abandoned
- 2003-01-13 MX MXPA04006717A patent/MXPA04006717A/es active IP Right Grant
- 2003-01-13 UA UA20040705602A patent/UA80692C2/uk unknown
- 2003-01-13 IL IL16264603A patent/IL162646A0/xx unknown
- 2003-01-13 US US10/342,044 patent/US7041699B2/en not_active Expired - Fee Related
- 2003-01-13 YU YU75003A patent/YU75003A/sh unknown
- 2003-01-13 CN CNB038020629A patent/CN100377706C/zh not_active Expired - Fee Related
- 2003-01-13 RU RU2004124384/15A patent/RU2301666C2/ru active IP Right Revival
- 2003-01-13 HU HU0500498A patent/HUP0500498A3/hu unknown
- 2003-01-13 AT AT03729250T patent/ATE382343T1/de active
- 2003-09-05 NO NO20033950A patent/NO20033950L/no not_active Application Discontinuation
-
2004
- 2004-06-25 ZA ZA200405075A patent/ZA200405075B/en unknown
- 2004-08-03 HR HR20040704A patent/HRP20040704A2/hr not_active Application Discontinuation
- 2004-08-11 LT LT2004076A patent/LT5240B/lt unknown
- 2004-09-09 LV LVP-04-93A patent/LV13248B/en unknown
-
2006
- 2006-02-06 US US11/348,927 patent/US20060142212A1/en not_active Abandoned
- 2006-06-07 HK HK06106522A patent/HK1086489A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL162646A0 (en) | A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer | |
| IL183953A0 (en) | Method of reducing oxidant induced damage of a food product, a pharmaceutical, or stored blood | |
| DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
| WO2005011734A3 (en) | Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer | |
| JO2373B1 (en) | W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors | |
| WO2002041837A3 (en) | Treatment of mucositis | |
| EP1181013A4 (en) | METHOD AND COMPOSITION FOR TREATING CANCER | |
| BG108225A (en) | Thiohydantoins and use thereof for treating diabetes | |
| IL144297A0 (en) | Composition for treating obesity and aesthetic treatment method | |
| WO2002081651A3 (en) | Polyphenolics for enhancing endothelial cell-mediated fibrinolysis | |
| BR0315580A (pt) | Derivados de metileno uréia | |
| KR100352030B1 (en) | Gum composition for removing nicotine | |
| HK1043052A1 (en) | Epigallocatechin-gallate for inhibiting angiogenesis | |
| EP1392328A4 (en) | ANTICANCER THERAPY | |
| WO2003008430A3 (en) | Porphyrin derivatives for photodynamic therapy | |
| IL162384A0 (en) | Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases | |
| HK1047707A1 (zh) | (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途 | |
| EP0819433A3 (en) | Compositions for increasing the efficacy of cancer drugs with tea catechin and/or theaflavin | |
| WO2006021888A3 (en) | Dihydrofolate reductase inhibition by epigallocatechin gallate compounds | |
| MXPA03001455A (es) | Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa. | |
| AU3919001A (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers | |
| BRPI0520221A2 (pt) | uso de uma composiÇço nutriente que compreende polifenàis de chÁ verde para tratamento de osteossarcoma | |
| MX2021010491A (es) | Tratamiento de fibromas con vitamina d y un agente tal como galato de epigalocatequina (egcg). | |
| BR0014751A (pt) | Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto | |
| WO2003080624A3 (en) | Dithiolopyrrolone derivatives useful in the treatment of proliferative diseases |